---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-010937"
form_type: "8-K"
ticker: "NKTX"
cik: "0001787400"
company_name: "Nkarta, Inc."
filed_at: "2023-03-30T23:59:59+00:00"
generated_at: "2026-06-17T09:31:47.591308+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nkarta CFO Nadir Mahmood resigns effective June 30, 2023; clinical timelines reaffirmed

## Summary
- CFO Nadir Mahmood resigns to become CEO of a private biotech; effective June 30, 2023.
- Nkarta initiates external search for new CFO.
- NKX101 clinical update on track for Q2 2023; NKX019 update expected in full year 2023.
- Mahmood will remain until June 30 to ensure smooth transition.

## SEC filing metadata
- accession: 0000950170-23-010937
- form_type: 8-K
- ticker: NKTX
- cik: 0001787400
- company_name: Nkarta, Inc.
- filed_at: 2023-03-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787400/000095017023010937/0000950170-23-010937-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787400/000095017023010937/nktx-20230328.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-010937
- JSON: https://secwatch.observer/filing/0000950170-23-010937.json
- Plain text: https://secwatch.observer/filing/0000950170-23-010937.txt

## Key facts
- Executive change
  Nadir Mahmood resigned as Chief Financial and Business Officer at Nkarta, Inc..
  - Action: resigned
  - Role: Chief Financial and Business Officer
  source text: Dr. Nadir Mahmood notified Nkarta, Inc. (the “Company”) of his decision to resign as Chief Financial and Business Officer of the Company to take a position as chief executive officer of a private biotechnology company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787400/000095017023010937/0000950170-23-010937-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.